Cargando…
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
Systemic therapy for metastatic renal cell carcinoma has continuously evolved over the last two decades. Significant improvements in overall survival and quality of life of patients with advanced disease have been observed. With the approval of combination therapies with PD(L)-1 immune checkpoint in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618488/ https://www.ncbi.nlm.nih.gov/pubmed/34830621 http://dx.doi.org/10.3390/jcm10225339 |